Latest News and Press Releases

PRESS RELEASEPreclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual MeetingMilan, ITALY – 14 May 2025 –...

Les données montrent les avantages d'un vecteur HSV-1 non réplicatif (nrHSV-1) unique intégrant deux transgènes présentant des cinétiques d'expression indépendantes.Ces vecteurs transduisent...

Data highlights advantages of single, non-replicative HSV-1 (nrHSV-1) vector hosting two transgenes with independent expression kineticsVectors also show high transduction rate of neurons in the CNS...

Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is pleased to award a $100,000 pediatric research grant to Dr. Carl Ernst, professor and scientist at McGill University, and his team....

Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights

Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing well and on target for potential BLA/MAA filings by mid-2026Anticipate...

~ AMT-130 granted Breakthrough Therapy designation by FDA ~ ~ Initial safety data from third cohort of Phase I/II study show AMT-130 continues to be generally well-tolerated, with no...

Milan, ITALY – 8 May 2025 – Genespire, a biotechnology company developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases, today announces an upcoming oral...

Dublin, May 07, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy in Ophthalmology Market - A Global and Regional Analysis: Focus on Indication, Vector Type, and Region - Analysis and Forecast, 2025-2035"...